FINHUB Insights

BIIB · Q1 FY26 · Jan 1 – Mar 31, 2026

Biogen Q1 FY26: where the revenue came from and where it went

Biogen Q1 FY26: revenue $2.5B (+2% year over year). Net profit $0.32B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2026
Reported
Jul 29, 2026 10-Q
Sankey diagram of Biogen's income statement for Q1 FY26: revenue of $2.48 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.48B +2% year over year
Gross profit$1.82B 73% margin
Operating profit$0.46B 19% margin
Net profit$0.32B 13% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 2.48 100% +2%
Cost of revenue−0.6627%
Gross profit1.8273% margin−1pp
SG&A−0.6125%+1pp
Other−0.7530%+0pp
Operating profit0.4619% margin+0pp
Tax−0.06
Interest & other costs−0.08
Net profit0.3213%+3pp
Filing on EDGAR More quarters of BIIB

Source of the numbers: tables in the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.